Follow
Dr. Balak Das Kurmi
Dr. Balak Das Kurmi
Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga-142001, INDIA
Verified email at isfcp.org
Title
Cited by
Cited by
Year
Solid lipid nanoparticles: A review on recent perspectives and patents
R Paliwal, SR Paliwal, R Kenwat, BD Kurmi, MK Sahu
Expert opinion on therapeutic patents 30 (3), 179-194, 2020
2262020
Micro-and nanocarrier-mediated lung targeting
BD Kurmi, J Kayat, V Gajbhiye, RK Tekade, NK Jain
Expert opinion on drug delivery 7 (7), 781-794, 2010
1472010
Transdermal drug delivery: opportunities and challenges for controlled delivery of therapeutic agents using nanocarriers
BD Kurmi, P Tekchandani, R Paliwal, S Rai Paliwal
Current drug metabolism 18 (5), 481-495, 2017
1022017
Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate
BD Kurmi, V Gajbhiye, J Kayat, NK Jain
Journal of pharmaceutical sciences 100 (6), 2311-2320, 2011
682011
Molecular approaches for targeted drug delivery towards cancer: A concise review with respect to nanotechnology
BD Kurmi, P Patel, R Paliwal, SR Paliwal
Journal of drug delivery science and technology 57, 101682, 2020
412020
Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach
BD Kurmi, R Paliwal, SR Paliwal
International journal of biological macromolecules 164, 2881-2894, 2020
382020
Nanomedicine to deal with cancer cell biology in multi-drug resistance
P Tekchandani, BD Kurmi, SR Paliwal
Mini reviews in medicinal chemistry 17 (18), 1793-1810, 2017
282017
Synthesis, characterization and in vivo evaluation of PEGylated PPI dendrimer for safe and prolonged delivery of insulin
AK Parashar, P Patel, AK Gupta, NK Jain, BD Kurmi
Drug Delivery Letters 9 (3), 248-263, 2019
252019
Nanocarriers in improved heparin delivery: recent updates
BD Kurmi, P Tekchandani, R Paliwal, S Rai Paliwal
Current pharmaceutical design 21 (30), 4509-4518, 2015
172015
Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs
L Kumari, Y Choudhari, P Patel, GD Gupta, D Singh, JM Rosenholm, ...
Life 13 (5), 1099, 2023
162023
Development and optimization of TPGS-based stealth liposome of doxorubicin using Box–Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast …
BD Kurmi, SR Paliwal
Journal of liposome research 32 (2), 129-145, 2022
152022
Chitosan-based nanocarriers for ophthalmic applications
R Paliwal, SR Paliwal, K Sulakhiya, BD Kurmi, R Kenwat, A Mamgain
Polysaccharide Carriers for Drug Delivery, 79-104, 2019
142019
Potential role of resveratrol and its nano-formulation as anti-cancer agent
A Kumar, BD Kurmi, A Singh, D Singh
Exploration of Targeted Anti-tumor Therapy 3 (5), 643, 2022
122022
Galactosylated TPGS micelles for docetaxel targeting to hepatic carcinoma: development, characterization, and biodistribution study
P Tekchandani, BD Kurmi, R Paliwal, SR Paliwal
AAPS PharmSciTech 21, 1-11, 2020
122020
Recent progress in histone deacetylase (HDAC) 1 inhibitors as anticancer agent
P Patel, SK Wahan, S Vishakha, BD Kurmi, GD Gupta, H Rajak, V Asati
Current Cancer Drug Targets 23 (1), 47-70, 2023
112023
Preparation and characterization of ligand anchored polymeric nanoparticles for the treatment of epilepsy
AK Parashar, BD Kurmi, P Patel
Pharmaspire 13 (1), 1-5, 2021
92021
Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer
L Kumari, L Mishra, P Patel, N Sharma, GD Gupta, BD Kurmi
Journal of Drug Targeting 31 (9), 889-907, 2023
82023
Generation dependent targeting potential of donepezil loaded poly (propylene imine) dendrimer through goat nasal mucosa
N Dwivedi, BD Kurmi, P Kesharwani, J Shah
Int J Phar Pharm Sci 10 (12), 80-87, 2018
82018
A Comprehensive Review on Synthesis of Dihydropyrimidione via Biginelli Reaction Catalysed by Reusable Magnetic Nano Catalyst (from 2020‐till date)
R Shakya, BD Kurmi, P Patel
Applied Organometallic Chemistry, e7075, 2023
62023
Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies
P Patel, SK Shrivastava, P Sharma, BD Kurmi, E Shirbhate, H Rajak
Journal of Biomolecular Structure and Dynamics 42 (1), 362-383, 2024
52024
The system can't perform the operation now. Try again later.
Articles 1–20